-
Path to Prescription: Popular Peptides May Gain Formal FDA-Backed Access
Peptides currently sold online without oversight may soon become available through legitimate prescription channels, a shift that could improve safety and consistency for patients seeking these therapies.
-
Understanding Peptide Therapy: A Guide to FDA-Approved Options and Their Benefits
A new overview highlights the growing landscape of peptide therapies, spotlighting which options have earned FDA approval and how they’re being used to support various aspects of health and wellness.
-
New Clinical Trial Explores Adding Durvalumab to Chemotherapy for Upper Urinary Tract Cancer
A phase II/III trial is investigating whether combining the immunotherapy durvalumab with standard chemotherapy before surgery could improve outcomes for patients with high-grade upper urinary tract cancer.
-
New Clinical Trial Explores Glofitamab as a Promising Option for Relapsed Mantle Cell Lymphoma
A new study is comparing glofitamab monotherapy to standard treatment combinations in patients with relapsed or refractory mantle cell lymphoma, offering hope for improved options in this challenging cancer.
-
New Clinical Trial Explores Nivolumab Plus Chemotherapy for Nasopharyngeal Carcinoma
A phase II trial is investigating whether combining the immunotherapy nivolumab with chemotherapy before radiation can improve outcomes for patients with nasopharyngeal carcinoma, while potentially reducing radiation exposure in children.
-
New Clinical Trial Explores Targeted Radioactive Therapy for Rare Thyroid Cancer
A new NIH-sponsored trial is testing 177Lu-DOTA-EB-TATE, a targeted radioactive peptide drug, in patients with treatment-resistant Hurthle cell thyroid cancer that has spread and no longer responds to standard radioactive iodine therapy.
-
New Clinical Trial Explores How Collagen Peptides May Help Knee Osteoarthritis
A new double-blind study in Türkiye will compare two collagen peptide formulations against placebo to see how they affect pain, function, and quality of life in adults with knee osteoarthritis.
-
ComboMATCH Screening Trial Opens New Doors for Precision Cancer Treatment
A nationwide screening trial called ComboMATCH is using genetic testing to connect patients with advanced solid tumors to targeted therapy combinations that may better match their tumor’s unique biology.
-
Asahi Kasei Advances Novel Peptide Candidate Into Phase I Trial for Autoimmune Diseases
Asahi Kasei has begun a Phase I clinical trial for a new peptide candidate aimed at treating autoimmune diseases, marking an early but promising step toward potential new therapeutic options.
-
Lilly’s Retatrutide Hits Major Milestone: Phase 3 Trial Shows Significant Weight Loss and Osteoarthritis Pain Relief
Eli Lilly’s triple agonist retatrutide succeeded in its first Phase 3 trial, delivering substantial average weight loss alongside meaningful relief from osteoarthritis-related joint pain in participants.